PE-22-28
PE-22-28. Seven-amino-acid spadin analog that blocks the TREK-1 potassium channel; fast antidepressant-like effects in mice.
How it works. Inhibits TREK-1 potassium channels, raising neuron excitability in mood circuits and promoting neurogenesis.
What the research supports. 1 graded claims. Strongest: Rapid antidepressant-like effects in mice (preclinical).
Side effects and interactions. 1 medication interaction listed. No serious side effects listed at normal doses.
Common forms. Available as Intranasal or injection (research only).
Community. Experiences from people who have tried PE-22-28. Anecdotes are not medical advice.
PE-22-28. Seven-amino-acid spadin analog that blocks the TREK-1 potassium channel; fast antidepressant-like effects in mice.
What it is
Derived from spadin, a fragment of the sortilin propeptide. In rodents it produced antidepressant-like effects within days and increased new neuron growth in the hippocampus. No human trials.
Also called
How it works
Inhibits TREK-1 potassium channels, raising neuron excitability in mood circuits and promoting neurogenesis.
Pathways
- TREK-1 channel inhibition
- Hippocampal neurogenesis
- Serotonergic neuron firing
Effects
- ↑Hippocampal neurogenesis (mice) increases
- ~Mood-related neuron firing modulates
What the research supports
Strong: consistent results across large trials or meta-analyses. Moderate: several trials, mostly positive. Limited: small or mixed studies. Preclinical: animal or cell research only.
Side effects & interactions
Common side effects
- Unknown in humans
Medication interactions
Unstudied combination; effects on mood circuits could add up.
Check any supplement–medication combination with your pharmacist before starting.
Common forms
- Intranasal or injection (research only)
Discussion
Loading discussion…